Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youth
Todd Testerman, Zhongyao Li, Brittany Galuppo, Joerg Graf, Nicola Santoro – 27 March 2022 – Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease and is often the precursor for more serious liver conditions such as nonalcoholic steatohepatitis and cirrhosis. Although the gut microbiome has been implicated in the development of NAFLD, the strong association of obesity with NAFLD and its effect on microbiome structure has made interpreting study outcomes difficult.